Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H00124 | GM2 gangliosidoses | ... gene cause deficiency of the beta-hexosaminidase A and result in Tay-Sachs disease. Mutations of the HEXB gene, encoding the beta-subunit, cause deficiency of both enzymes (beta-hexosaminidase A and B) ... | Inherited metabolic disorder, Lysosomal disease |
(Type I) HEXA [HSA:3073] [KO:K12373] (Type II) HEXB [HSA:3074] [KO:K12373] (AB variant) GM2A [HSA:2760] [KO:K12383] |
|
H00426 | Gangliosidosis | Defects in the degradation of ganglioside is a group of autosomal recessive lysosomal storage diseases caused by deficient activities of enzymes or their activators that play important roles in the degradation ... | Inherited metabolic disorder, Lysosomal disease |
(GM1G) GLB1 [HSA:2720] [KO:K12309] (GM2G1) HEXA [HSA:3073] [KO:K12373] (GM2G2) HEXB [HSA:3074] [KO:K12373] (GM2AB) GM2A [HSA:2760] [KO:K12383] |
|
H02017 |
Sandhoff disease GM2 gangliosidoses type II |
Sandhoff disease is an autosomal recessive lysosomal storage disorder caused by mutations in HEXB that encodes beta-hexosaminidase subunit beta. Sandhoff disease is characterized by combined deficiency ... | Inherited metabolic disorder, Lysosomal disease | HEXB [HSA:3074] [KO:K12373] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |